Postmenopausal dysgerminoma: unveiling a rare ovarian tumour a case report and review of literature
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20251599Keywords:
Ovarian germ cell tumours, Yolk sac tumour, DysgerminomaAbstract
Ovarian germ cell tumours (OGCTs) account for 2-5% of ovarian malignancies with an annual incidence of 1:100000 and typically occurs in young women and adolescents. A pure ovarian dysgerminoma in a postmenopausal female is a rare phenomenon. We report a case of 48-year-old female postmenopausal since 3 years presented to gynaecology opd with pain lower abdomen. On clinical examination an abdominopelvic mass enlarged to 18-20-week gravid uterus size. All tumour markers were normal except lactate dehydrogenase raised to 1375. On imaging a well-defined large solid cystic heterogenous mass arising from left adnexa, suggestive of neoplastic etiology. Staging laparotomy done. A final diagnosis of ovarian dysgerminoma was made on histopathological examination.
Metrics
References
Arai T, Kitayama Y, Koda KO. Ovarian mucinous cystadenocarcinoma with yolk sac tumor in a 71-year-old woman. Int J Gynecol Pathol. 1999;18(3):277-80. DOI: https://doi.org/10.1097/00004347-199907000-00015
Gershenson DM, Del Junco G, Copeland LJ, Rutledge FN. Mixed germ cell tumors of the ovary. Obstet Gynecol. 1984;64(2):200-6.
Kurman RJ, Ellenson LH, Vang R. Germ cell tumors of the ovary. In: Kurman RJ, Ellenson LH, Ronnett BM, eds. Blaustein's Pathology of the Female Genital Tract. 6th ed. New York, NY: Springer. 2011;855-64. DOI: https://doi.org/10.1007/978-1-4419-0489-8
Boussios S, Ayoma A, Steve H, Michele M, Jennifer McL, Alicia O, et al. Malignant ovarian germ cell tumors in postmenopausal patients: the Royal Marsden experience and literature review. Anticancer Res. 2015;35(12):6713-22.
Hyseni N, Llullaku S, Jashari H, Zahiti K, Hyseni F, Kurshumliu F, et al. Advanced ovarian dysgerminoma infiltrating both ovaries and uterus in a 7-year-old girl. Case Rep Oncol Med. 2014;2014:910852. DOI: https://doi.org/10.1155/2014/910852
Chu SM, Ming YC, Chao HC, Lai JY, Chen JC, Yung CP, et al. Ovarian tumors in the pediatric age group: 37 cases treated over an 8-year period. Chang Gung Med J. 2010;33(2):152-6.
Pectasides D, Pectasides E, Kassanos D. Germ cell tumors of the ovary. Cancer Treat Rev. 2008;34:427-41. DOI: https://doi.org/10.1016/j.ctrv.2008.02.002
Zhao S, Fan S, Lei B, Caiting C, Haiming L, Qiufeng Y, et al. Pure dysgerminoma of the ovary: CT and MRI features with pathological correlation in 13 tumors. J Ovar Res. 2020;13(1):71. DOI: https://doi.org/10.1186/s13048-020-00674-z
Kilic C, Cakir C, Yuksel D, Fatih K, Fulya K, Sevgi K, et al. Ovarian dysgerminoma: a tertiary center experience. J Adolesc Young Adult Oncol. 2020;10(3):303-8. DOI: https://doi.org/10.1089/jayao.2020.0087
Forstner R. CT and MRI in Ovarian Carcinoma. In: Forstner R, Cunha TM, Hamm B, eds. CT and MRI in Ovarian Carcinoma. 2nd ed. Cham, Switzerland: Springer. 2017;287-323. DOI: https://doi.org/10.1007/174_2017_17
Clement PB, Jennifer S, Robert HY. Atlas of Gynecologic Surgical Pathology. Edinburgh, UK: Elsevier. 2020;360-361.
Hoffman B, Schorge J, Schaffer J, Halvorson L, Bradshaw K, Cunningham F. Williams Gynaecology. 2nd ed. Massachusetts: McGraw Hill Professional. 2012;1401.
Barakat RR, Andrew B, Maurie M, Marcus ER. Principles and Practice of Gynecologic Oncology. 3rd ed. Philadelphia, PA: Wolters Kluwer Health. 2013;851-60.
Konar H. DC Dutta's Textbook of Gynecology. 7th ed. New Delhi, India: Jaypee Brothers Medical Publishers. 2016;584.
Hoffman B, Schorge J, Schaffer J, Halvorson L, Bradshaw K, Cunningham F. Williams Gynaecology. 2nd ed. Massachusetts: McGraw Hill Professional. 2012;1401.
Funt SA, Deaglan JMc, Stephanie T, Andrea K, Devon O'D, Sujata P, et al. Four cycles of etoposide plus cisplatin for patients with good-risk advanced germ cell tumors. Oncologist. 2021;26(6):483-91. DOI: https://doi.org/10.1002/onco.13719
Talerman A, Vang R. Germ cell tumors of the ovary. In: Kurman RJ, Ellenson LH, eds. Blaustein's Pathology of the Female Genital Tract. New York, NY: Springer. 2019;1047-124. DOI: https://doi.org/10.1007/978-3-319-46334-6_16
Tsimberidou AM, Henry HV, Vivek S, Filip J, Sarina PP, Bulent Y, et al. Pembrolizumab in patients with advanced metastatic germ cell tumors. Oncologist. 2021;26(7):558-1098. DOI: https://doi.org/10.1002/onco.13682